A novel acetylcholinesterase inhibitor and calcium channel blocker SCR-1693 improves Aβ25–35-impaired mouse cognitive function

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Psychopharmacology

• Publication date

  2016-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00213-015-4133-5PMID 26554390
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug treatments in Alzheimer's disease.

  2016cited by this paper
• Simvastatin prevents β-amyloid(25-35)-impaired neurogenesis in hippocampal dentate gyrus through α7nAChR-dependent cascading PI3K-Akt and increasing BDNF via reduction of farnesyl pyrophosphate.

  2015cited by this paper
• Drug treatments for Alzheimer's disease.

  2014cited by this paper
• Therapeutics of Alzheimer's disease: Past, present and future.

  2014cited by this paper
• Novel Multipotent AChEI-CCB Attenuates Hyperhomocysteinemia-Induced Memory Deficits and Neuropathologies in Rats

  2014influential reference
• Whole-cell patch-clamp recordings of Ca2+ currents from isolated neonatal mouse dorsal root ganglion (DRG) neurons.

  2014cited by this paper
• Simvastatin Exerts Antiamnesic Effect in Aβ25‐35‐Injected Mice

  2014influential reference
• Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines.

  2014cited by this paper
• The interactions of azure B, a metabolite of methylene blue, with acetylcholinesterase and butyrylcholinesterase.

  2014cited by this paper
• Biomarker‐Driven Therapeutic Management of Alzheimer's Disease: Establishing the Foundations

  2013cited by this paper
• Memantine Rescues Transient Cognitive Impairment Caused by High-Molecular-Weight Aβ Oligomers But Not the Persistent Impairment Induced by Low-Molecular-Weight Oligomers

  2013cited by this paper
• Expression and Pharmacology of Endogenous Cav Channels in SH-SY5Y Human Neuroblastoma Cells

  2013cited by this paper
• Blockade of Tau Hyperphosphorylation and Aβ1–42 Generation by the Aminotetrahydrofuran Derivative ANAVEX2-73, a Mixed Muscarinic and σ1 Receptor Agonist, in a Nontransgenic Mouse Model of Alzheimer’s Disease

  2013cited by this paper
• Protective effect of xanthoceraside against β-amyloid-induced neurotoxicity in neuroblastoma SH-SY5Y cells

  2013cited by this paper
• Neuroprotective effects of donepezil against cholinergic depletion

  2013cited by this paper
• Potassium Current Is Not Affected by Long-Term Exposure to Ghrelin or GHRP-6 in Somatotropes GC Cells

  2013influential reference
• Calcium Channel Blockers and Alzheimer's Disease: Potential Relevance in Treatment Strategies of Metabolic Syndrome

  2012cited by this paper
• Comparative Impact of Voltage-Gated Calcium Channels and NMDA Receptors on Mitochondria-Mediated Neuronal Injury

  2012cited by this paper
• Anti-amnesic effect of neurosteroid PREGS in Aβ25-35-injected mice through σ1 receptor- and α7nAChR-mediated neuroprotection.

  2012cited by this paper
• Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: the case for isradipine.

  2011cited by this paper
• Neuroprotection of paliperidone on SH-SY5Y cells against β-amyloid peptide25-35, N-methyl-4-phenylpyridinium ion, and hydrogen peroxide-induced cell death

  2011cited by this paper
• Neuroprotective effects of Eucommia ulmoides Oliv. Bark on amyloid beta(25-35)-induced learning and memory impairments in mice.

  2011cited by this paper
• New Acetylcholinesterase Inhibitors for Alzheimer's Disease

  2011cited by this paper
• Pharmacokinetic and Pharmacodynamic Properties of Cholinesterase Inhibitors Donepezil, Tacrine, and Galantamine in Aged and Young Lister Hooded Rats

  2011cited by this paper
• Selective Antihypertensive Dihydropyridines Lower Aβ Accumulation by Targeting both the Production and the Clearance of Aβ across the Blood-Brain Barrier

  2011cited by this paper
• Alzheimer's disease.

  2011cited by this paper
• Dysregulated phosphorylation of Ca2+/calmodulin‐dependent protein kinase II‐α in the hippocampus of subjects with mild cognitive impairment and Alzheimer’s disease

  2011cited by this paper
• Time-course and regional analyses of the physiopathological changes induced after cerebral injection of an amyloid β fragment in rats.

  2011cited by this paper
• Xanthoceraside attenuates amyloid β peptide25–35-induced learning and memory impairments in mice

  2011cited by this paper
• Acute effects of donepezil in healthy young adults underline the fractionation of executive functioning

  2011cited by this paper
• L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer's disease.

  2011cited by this paper
• Alzheimer's disease.

  2010cited by this paper
• Daidzein induces MCF-7 breast cancer cell apoptosis via the mitochondrial pathway.

  2010cited by this paper
• Nicotine exacerbates tau phosphorylation and cognitive impairment induced by amyloid-beta 25-35 in rats.

  2010cited by this paper
• DMXB (GTS‐21) ameliorates the cognitive deficits in beta amyloid  25–35 − injected mice through preventing the dysfunction of alpha7 nicotinic receptor

  2010influential reference
• Phosphorylation Changes of CaMKII, ERK1/2, PKB/Akt Kinases and CREB Activation During Early Long-Term Potentiation at Schaffer Collateral-CA1 Mouse Hippocampal Synapses

  2010cited by this paper
• Tacripyrines, the first tacrine-dihydropyridine hybrids, as multitarget-directed ligands for the treatment of Alzheimer's disease.

  2009cited by this paper
• Calcium dysregulation in Alzheimer's disease: from mechanisms to therapeutic opportunities.

  2009cited by this paper
• Protective effect of stilbenes containing extract-fraction from Cajanus cajan L. on Abeta(25-35)-induced cognitive deficits in mice.

  2009cited by this paper
• Cholinesterase inhibitors and beyond.

  2009cited by this paper
• Linking Calcium to A and Alzheimer's Disease

  2008cited by this paper
• Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease.

  2008cited by this paper
• Multi-target-directed ligands to combat neurodegenerative diseases.

  2008cited by this paper
• Donepezil: potential neuroprotective and disease-modifying effects

  2008cited by this paper
• A neural cell adhesion molecule-derived peptide reduces neuropathological signs and cognitive impairment induced by Abeta25-35.

  2007cited by this paper
• A neural cell adhesion molecule–derived peptide reduces neuropathological signs and cognitive impairment induced by Aβ25-35

  2007cited by this paper
• Donepezil: an update

  2007cited by this paper
• Alzheimer's disease

  2006cited by this paper
• The anti‐amnesic and neuroprotective effects of donepezil against amyloid β25‐35 peptide‐induced toxicity in mice involve an interaction with the σ1 receptor

  2006influential reference
• Full Reversal of Alzheimer's Disease-Like Phenotype in a Mouse Model with Conditional Overexpression of Glycogen Synthase Kinase-3

  2006cited by this paper
• Up-regulation of nicotinic acetylcholine receptors by central-type acetylcholinesterase inhibitors in rat cortical neurons.

  2005cited by this paper
• Protective effect of donepezil against Abeta(1-40) neurotoxicity in rat septal neurons.

  2005cited by this paper
• Intraneuronal amyloid‐β1‐42 production triggered by sustained increase of cytosolic calcium concentration induces neuronal death

  2004cited by this paper
• Amyloid-β(25–35)-induced memory impairments correlate with cell loss in rat hippocampus

  2004cited by this paper
• Single intracerebroventricular administration of amyloid-beta (25-35) peptide induces impairment in short-term rather than long-term memory in rats.

  2003cited by this paper
• A beta 25-35-induced depression of long-term potentiation in area CA1 in vivo and in vitro is attenuated by verapamil.

  2003cited by this paper
• Calcium channels — basic aspects of their structure, function and gene encoding; anesthetic action on the channels — a review

  2002cited by this paper
• Calcium dyshomeostasis and intracellular signalling in alzheimer's disease

  2002cited by this paper
• Voltage-gated channels block nicotinic regulation of CREB phosphorylation and gene expression in neurons.

  2001cited by this paper
• Chronic Donepezil Treatment Is Associated with Slowed Cognitive Decline in Alzheimer’s Disease

  2001cited by this paper
• Deficiency of presenilin‐1 increases calcium‐dependent vulnerability of neurons to oxidative stress in vitro

  2001cited by this paper
• alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity.

  2001cited by this paper
• α7 Nicotinic Receptor Transduces Signals to Phosphatidylinositol 3-Kinase to Block A β-Amyloid-induced Neurotoxicity*

  2001cited by this paper
• Alzheimer's disease and Aβ toxicity: from top to bottom

  2001cited by this paper
• Alzheimer's disease and Abeta toxicity: from top to bottom.

  2001cited by this paper
• Donepezil hydrochloride (E2020) and other acetylcholinesterase inhibitors.

  2000influential reference
• In vitro aggregation facilities beta-amyloid peptide-(25-35)-induced amnesia in the rat.

  1997cited by this paper
• In vitro aggregation facilitates β-amyloid peptide-(25–35)-induced amnesia in the rat

  1997cited by this paper
• Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction.

  1996cited by this paper
• Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein.

  1994cited by this paper
• Two types of high voltage-activated calcium channels in SH-SY5Y human neuroblastoma cells.

  1993cited by this paper
• An investigation into the formation of stable, protein-reactive and cytotoxic metabolites from tacrine in vitro. Studies with human and rat liver microsomes.

  1993cited by this paper
• Calcium currents in aged rat dorsal root ganglion neurones.

  1993cited by this paper
• An essential role for postsynaptic calmodulin and protein kinase activity in long-term potentiation

  1989cited by this paper
• Psychopharmacology

  1979cited by this paper
• A new and rapid colorimetric determination of acetylcholinesterase activity.

  1961cited by this paper
• The determination of enzyme inhibitor constants.

  1953cited by this paper

• Cholinesterase-based inhibitors as multitarget small molecules for the therapy of Alzheimer's disease.

  2025cites this paper
• LRP1-mediated p-tau propagation contributes to cognitive impairment after chronic neuropathic pain in rats.

  2024cites this paper
• True or False? Alzheimer's disease is Type 3 Diabetes: Evidences from Bench to Bedside.

  2024cites this paper
• Innovative pathological network‐based multitarget approaches for Alzheimer's disease treatment

  2024cites this paper
• Probing the interactions between amyloidogenic proteins and bio-membranes.

  2023cites this paper
• The pathomimetic oAβ25-35 model of Alzheimer's disease: Potential for screening of new therapeutic agents.

  2023cites this paper
• Potential role of Drug Repositioning Strategy (DRS) for management of tauopathy.

  2021cites this paper
• A new mode of Thinfilm and Nanofiber for burst release of the drug for Alzheimer disease; A complete scenario from dispersible polymer to formulation methodology.

  2021cites this paper
• A GLP-1/GIP/Gcg receptor triagonist improves memory behavior, as well as synaptic transmission, neuronal excitability and Ca2+ homeostasis in 3xTg-AD mice.

  2020cites this paper
• SCR-1693 inhibits tau phosphorylation and improves insulin resistance associated cognitive deficits.

  2020cites this paper
• PLGA Microspheres with Alginate-Coated Large Pores for the Formulation of an Injectable Depot of Donepezil Hydrochloride

  2020cites this paper
• Neuroprotective Effect of 2-Aminoethoxydiphenyl Borate (2-APB) in Amyloid β-Induced Memory Dysfunction: A Mechanistic Study

  2020cites this paper
• Nonequilibrium Molecular Dynamics Simulations of Infrared Laser-Induced Dissociation of a tetrameric Aβ42 β-Barrel in a Neuronal Membrane Model.

  2020cites this paper
• The Structural Hybrids of Acetylcholinesterase Inhibitors in the Treatment of Alzheimer’s Disease: A Review

  2019cites this paper
• Moringa Oleifera Alleviates Homocysteine-Induced Alzheimer’s Disease-Like Pathology and Cognitive Impairments

  2018cites this paper
• Effects of Donepezil Hydrochloride on Neuronal Response of Pyramidal Neurons of the CA1 Hippocampus in Rat Model of Alzheimer’s Disease

  2018cites this paper
• Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer's disease.

  2018cites this paper
• Methanolic extract of Tamarix Gallica attenuates hyperhomocysteinemia induced AD-like pathology and cognitive impairments in rats

  2018cites this paper
• Interaction between amyloidogenic proteins and biomembranes in protein misfolding diseases: Mechanisms, contributors, and therapy.

  2018cites this paper
• Azelnidipine Attenuates the Oxidative and NFκB Pathways in Amyloid-β-Stimulated Cerebral Endothelial Cells.

  2018cites this paper
• Tacrines as Therapeutic Agents for Alzheimer's Disease. IV. The Tacripyrines and Related Annulated Tacrines.

  2018cites this paper
• The Role of Sigma-1 Receptors in an Alzheimer's Disease Mouse Model

  2017cites this paper
• Editorial: Multi-target Drug Discovery - Part I.

  2017cites this paper
• Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease

  2016cites this paper